Cannara Biotech (LOVFF) Income Statement
12 Followers
Cannara Biotech Income Statement
Last quarter (Q3 2026), Cannara Biotech's total revenue was C$31.83M, an increase of 16.45% from the same quarter last year. In Q3, Cannara Biotech's net income was C$4.84M. See Cannara Biotech’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Aug 25 | Aug 24 | Nov 23 | Aug 22 | Nov 21 |
|---|---|---|---|---|---|
| C$ 107.32M | C$ 81.75M | C$ 57.26M | C$ 35.84M | C$ 17.02M | |
| C$ 47.22M | C$ 29.79M | C$ 27.23M | C$ 16.74M | C$ 11.86M | |
| C$ 25.02M | C$ 19.71M | C$ 15.34M | C$ 12.36M | C$ 10.04M | |
| Depreciation and Amortization | C$ 6.68M | C$ 6.35M | C$ 4.94M | C$ 3.92M | C$ 3.03M |
| C$ 28.46M | C$ 15.16M | C$ 15.77M | C$ 7.85M | C$ 4.63M | |
| C$ 22.20M | C$ 10.08M | C$ 11.89M | C$ 4.39M | C$ 1.82M | |
| C$ -4.10M | C$ -5.59M | C$ -4.94M | C$ -2.08M | C$ -3.35M | |
| C$ 18.10M | C$ 4.48M | C$ 6.95M | C$ 2.31M | C$ -1.53M | |
| C$ 13.08M | C$ 6.44M | C$ 6.95M | C$ 2.31M | C$ -1.53M | |
| Per Share Metrics | |||||
| Basic EPS | C$ 0.14 | C$ 0.07 | C$ 0.08 | C$ 0.03 | C$ -0.04 |
| Diluted EPS | C$ 0.14 | C$ 0.07 | C$ 0.08 | C$ 0.03 | C$ -0.04 |
| Weighted Average Shares Outstanding | 92.37M | 90.07M | 89.30M | 87.67M | 76.52M |
| Weighted Average Shares Outstanding (Diluted) | 92.37M | 91.39M | 89.30M | 87.84M | 76.52M |
Currency in CAD
